Want to see AU:EMV full AI Analyst Report?

EMvision Medical Devices Ltd. (EMV) Price & Analysis

7 Followers

EMV Stock Chart & Stats

AU$1.72

AU$0.06(3.90%)

At close: Jul 27 4:00 PM EDT

AU$1.72

AU$0.06(3.90%)

Day’s Range― - ―

52-Week RangeAU$1.47 - AU$1.96

Previous CloseN/A

Volume21.03K

Average Volume (3M)30.81K

Market Cap

AU$145.94M

Enterprise ValueAU$127.13M

Total Cash (Recent Filing)AU$17.10M

Total Debt (Recent Filing)AU$3.41M

Price to Earnings (P/E)―

Beta0.59

Next Earnings

Feb 24, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.09

Shares Outstanding92,955,560

10 Day Avg. Volume31,106

30 Day Avg. Volume30,806

Financial Highlights & Ratios

PEG Ratio0.98

Price to Book (P/B)8.78

Price to Sales (P/S)0.00

P/FCF Ratio-21.73

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$3.15

Price Target Upside83.14% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-0.11

Revenue Forecast (FY)AU$5.00M

Bulls Say, Bears Say

Bulls Say

Portable Imaging PlatformA portable, non-invasive system aimed at rapid stroke and neurological assessment addresses a clear clinical workflow need. If development succeeds, point-of-care deployment could differentiate EMvision from larger, less portable imaging approaches and support adoption across emergency and bedside settings.

Moderate LeverageModerate and declining leverage reduces dependence on debt financing and limits pressure from interest obligations. The approximately 0.22 debt-to-equity level in 2026 gives EMvision more balance-sheet flexibility to continue development and pursue commercialization while managing a loss-making phase.

Earlier Revenue TractionStrong revenue growth during 2022–2024 indicates the company previously demonstrated an ability to generate commercial revenue. Although subsequent results were materially weaker, that earlier traction provides evidence of potential market engagement if the business can restore product activity and establish a more consistent revenue base.

Bears Say

Revenue InterruptionThe move from earlier revenue growth to zero revenue indicates a severe interruption in commercial activity and makes near-term operating visibility weak. Without a stable revenue base, EMvision has limited demonstrated ability to fund operations internally or convert its technology development into recurring sales.

Persistent LossesRecurring operating and net losses show that the current business model has not yet reached economic sustainability. Deeply negative margins can consume equity over time, constrain investment capacity, and increase the execution burden on management to achieve commercialization and improve operating leverage.

Ongoing Cash BurnPersistent negative operating and free cash flow means EMvision continues to consume cash rather than self-fund development. The worsening 2026 free cash flow burn points to rising funding needs, which could require additional capital and reduce financial flexibility before revenue becomes dependable.

EMvision Medical Devices Ltd. News

EMVision Sets November Date for 2026 Annual General Meeting

The latest announcement is out from EMvision Medical Devices Ltd. ( ($AU:EMV) ). EMVision Medical Devices Ltd has...

6h ago

EMV

EMVision’s emu Brain Scanner Gains Traction in Mayo Clinic Stroke Trial

The latest update is out from EMvision Medical Devices Ltd. ( ($AU:EMV) ). Mayo Clinic Florida has begun...

4d ago

EMV

EMvision Sets November Date and Nomination Deadline for 2026 AGM

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has provided an announcement. EMvision Medical Devices has scheduled its Annual...

24d ago

EMV

EMVision Secures $4.3m R&D Tax Refund to Advance Stroke Diagnostic Devices

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has issued an update. EMVision Medical Devices has received a $4.3...

25d ago

EMV

EMVision advances portable stroke scanner with successful mobile trial and new funding

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has issued an update. EMVision has completed Stage 1 of its...

1M ago

EMV

EMvision Issues New Performance Rights Under Employee Incentive Scheme

An update from EMvision Medical Devices Ltd. ( ($AU:EMV) ) is now available. EMvision Medical Devices Ltd. has...

1M ago

EMV

EMVision advances regional stroke study to support bedside scanner rollout

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has shared an announcement. EMVision Medical Devices is advancing preparations for...

2M ago

EMV

EMVision passes 200-patient milestone in pivotal stroke imaging trial

An announcement from EMvision Medical Devices Ltd. ( ($AU:EMV) ) is now available. EMVision Medical Devices has passed...

2M ago

EMV

EMVision updates registered office without operational changes

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has shared an announcement. EMVision Medical Devices Ltd has updated its...

2M ago

EMV

EMVision Advances Pivotal Brain Scanner Trial and Strengthens Funding Base

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has shared an announcement. EMVision reported strong progress in its pivotal...

3M ago

EMV

EMV FAQ

What was EMvision Medical Devices Ltd.’s price range in the past 12 months?

EMvision Medical Devices Ltd. lowest share price was AU$1.47 and its highest was AU$1.96 in the past 12 months.

What is EMvision Medical Devices Ltd.’s market cap?

EMvision Medical Devices Ltd.’s market cap is AU$145.94M.

When is EMvision Medical Devices Ltd.’s upcoming earnings report date?

EMvision Medical Devices Ltd.’s upcoming earnings report date is Feb 24, 2027 which is in 124 days.

How were EMvision Medical Devices Ltd.’s earnings last quarter?

EMvision Medical Devices Ltd. released its earnings results on Aug 23, 2026. The company reported -AU$0.047 earnings per share for the quarter.

Is EMvision Medical Devices Ltd. overvalued?

According to Wall Street analysts EMvision Medical Devices Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does EMvision Medical Devices Ltd. pay dividends?

EMvision Medical Devices Ltd. does not currently pay dividends.

What is EMvision Medical Devices Ltd.’s EPS estimate?

EMvision Medical Devices Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EMvision Medical Devices Ltd. have?

EMvision Medical Devices Ltd. has 92,955,560 shares outstanding.

What happened to EMvision Medical Devices Ltd.’s price movement after its last earnings report?

EMvision Medical Devices Ltd. reported an EPS of -AU$0.047 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of EMvision Medical Devices Ltd.?

Currently, no hedge funds are holding shares in AU:EMV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

EMvision Medical Devices Ltd. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-46.84%

Trailing 12-Months

Asset Growth

47.92%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

EMvision Medical Devices Ltd.

EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.

EMvision Medical Devices Ltd. (EMV) Earnings & Revenues

Historic Earnings Reports

EMV Stock 12 Month Forecast

Average Price Target

AU$3.15

▲(83.14% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","2":"AU$2","3":"AU$3","4":"AU$4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$3.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$3.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$3.15</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.6915384615384617,1.813076923076923,1.9346153846153846,2.056153846153846,2.1776923076923076,2.2992307692307694,2.420769230769231,2.542307692307692,2.663846153846154,2.7853846153846153,2.9069230769230767,3.0284615384615385,{"y":3.15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.6915384615384617,1.813076923076923,1.9346153846153846,2.056153846153846,2.1776923076923076,2.2992307692307694,2.420769230769231,2.542307692307692,2.663846153846154,2.7853846153846153,2.9069230769230767,3.0284615384615385,{"y":3.15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.6915384615384617,1.813076923076923,1.9346153846153846,2.056153846153846,2.1776923076923076,2.2992307692307694,2.420769230769231,2.542307692307692,2.663846153846154,2.7853846153846153,2.9069230769230767,3.0284615384615385,{"y":3.15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.93,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.77,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.775,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.755,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.57,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.88,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.49,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.595,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.57,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >